“State of Lung Cancer” Report Shows Need for Increased Screening Leading to Early Detection“The American Lung Association’s 2024 “State of Lung Cancer” report ranks Florida 17 out of 47 surveyed states for survival of lung cancer at 29.1%. The report also...
New Cancer Vaccine May Boost Immunotherapy in Treating Lung Cancer“Non-small cell lung cancer is the most common type of lung cancer, accounting for about 85% of cases. While treatment advances have improved outcomes for some patients, advanced non-small cell lung...
Lung Cancer Awareness Month 2024“Lung cancer is the most common cancer type and the most common cause of cancer death in the world. The most recent global estimates from the International Agency for Research on Cancer (IARC) indicate that in 2022 almost 2.5 million...
New lung cancer screening initiative looks to increase access to care“Key Takeaways – The initiative targets low-income, uninsured, and minority populations to reduce lung cancer disparities through bilingual support and no-cost screenings. Over 700 eligible...
Roche’s Alecensa receives NICE recommendation to treat ALK-positive lung cancer“Just under 100 non-small cell lung cancer patients in England will be eligible for the drug” FDA Presses Clinical Hold Button For BioNTech’s Partner Late-Stage Trial Of...
Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study“Obesity may be associated with an increased overall survival among male patients treated with chemotherapy,...
More News and Updates